Premium
The effect of reserpine, desipramine and thyroid hormone on alpha 1a‐ and alpha 1b‐adrenoceptor binding sites: evidence for a subtype‐ specific regulation.
Author(s) -
Hanft G.,
Gross G.
Publication year - 1990
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1990.tb05482.x
Subject(s) - prazosin , desipramine , reserpine , alpha (finance) , endocrinology , radioligand assay , medicine , radioligand , alpha 2 adrenergic receptor , hormone , binding site , adrenergic receptor , chemistry , receptor , biology , pharmacology , antagonist , biochemistry , construct validity , nursing , hippocampus , patient satisfaction , antidepressant
Using radioligand binding techniques we studied whether alpha 1a‐ and alpha 1b‐adrenoceptor recognition sites can be regulated independently by drugs and hormones. In rat cerebral cortex subchronic treatment with reserpine enhanced the number of [3H]‐prazosin binding sites and the proportion of alpha 1b binding sites. Desipramine treatment which did not alter Bmax values, increased the proportion of alpha 1a and decreased alpha 1b binding sites. In rat myocardium hypothyroidism decreased alpha 1b‐adrenoceptor binding sites. These results suggest that alpha 1‐adrenoceptors are regulated in a subtype‐selective manner.